Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices were developed to enable the constant monitoring of regional and global infection processes. Additionally, innumerable lateral flow test devices are frequently used for determination of different clinical parameters, food safety, and environmental factors. Since common LFAs rely on non-biodegradable nitrocellulose membranes, we focused on their replacement by cellulose-composed, biodegradable papers. We report the development of cellulose paper-based lateral flow immunoassays using a carbohydrate-binding module-fused to detection antibodies. Studies regarding the protein binding capacity and potential protein wash-off effects on cellulose pape...
Paper-based platforms are ideal for on-site surveillance of infectious diseases in low-resource sett...
Thesis (Ph.D.)--University of Washington, 2019Point-of-care diagnostics have enabled clinical testin...
Thesis (Ph.D.)--University of Washington, 2019Point-of-care diagnostics have enabled clinical testin...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Lateral flow immunoassays (LFIAs) serve as rapid and convenient tools for disease screening. However...
An advanced paper-based LFIA using engineered cellulose-binding protein linker fused with antibody-b...
Bioactive paper is a product that includes functionalities based on selective reactions of biomolecu...
The Lateral Flow Immuno Assay (LFIA) is a well-established technique that provides immediate results...
Sandwich lateral flow assay (LFA) is one of the most successfully commercialized paper-based biosens...
Paper-based platforms are ideal for on-site surveillance of infectious diseases in low-resource sett...
Thesis (Ph.D.)--University of Washington, 2019Point-of-care diagnostics have enabled clinical testin...
Thesis (Ph.D.)--University of Washington, 2019Point-of-care diagnostics have enabled clinical testin...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Since the pandemic outbreak of Covid-19 in December 2019, several lateral flow assay (LFA) devices w...
Lateral flow immunoassays (LFIAs) serve as rapid and convenient tools for disease screening. However...
An advanced paper-based LFIA using engineered cellulose-binding protein linker fused with antibody-b...
Bioactive paper is a product that includes functionalities based on selective reactions of biomolecu...
The Lateral Flow Immuno Assay (LFIA) is a well-established technique that provides immediate results...
Sandwich lateral flow assay (LFA) is one of the most successfully commercialized paper-based biosens...
Paper-based platforms are ideal for on-site surveillance of infectious diseases in low-resource sett...
Thesis (Ph.D.)--University of Washington, 2019Point-of-care diagnostics have enabled clinical testin...
Thesis (Ph.D.)--University of Washington, 2019Point-of-care diagnostics have enabled clinical testin...